Par reorganizes, drops 190 employees

Par Pharmaceutical will cut 190 jobs--more than a fourth of its workforce--in an effort to contain costs over the next year. Sixty of the 190 workers will see pink slips before they ring in the new year; the rest will be gone by mid- 2009. 

Par's chief operating officer will be leaving the company as well.    

The 20-year-old company will focus on its most profitable products and "align the company's cost structure with the size of its operations and development pipeline," according to the CEO, Pat LePor.  Par execs believe the company's restructuring efforts will result in annual savings of up to $55 million. 

- read the story at
- find the Pharmalot blog post 


Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.